News & Events

• September 1, 2010
  

  Translational Medicine and the Value of Biomarker Qualification

• September 1, 2010
  

  Pharmacometrics As A Discipline Is Entering The “Industrialization” Phase: Standards, Automation, Knowledge Sharing, And Training Are Critical For Future Success

• June 11, 2010
  

  Public Release of Alzheimer’s Clinical Trial Data by Pharmaceutical Researchers

• June 10, 2010
  

  Coalition Against Major Diseases Introduces the First Combined Pharmaceutical Trial Data on Neuro-degenerative Diseases

  A new database of more than 4,000 Alzheimer’s disease patients who have participated in 11 industry-sponsored clinical trials will be released today by the Coalition Against Major Diseases (CAMD).
• June 10, 2010
  

  Critical Path Institute’s Predictive Safety Testing Consortium Announces First-Ever Qualification Decision by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

  For the first time, new biomarker tests to detect drug-induced kidney injury have been accepted by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).